Three facets of employee wellness: the potential moderating influences of exercise, mindfulness-based practices, and vacation on select worker characteristics

Current research notes a disconnect between well-being programs offered by organizations and those most valued by employees (Agarwal, Bersin, Lahiri, Schwartz, & Violini, 2018). Thus, the current study attempts to better understand the potential influence of health-driven, leisure activities on three worker characteristics, namely, workaholism, work stress, and work engagement. With a greater understanding, we hope to emphasize the importance of comprehensive well-being programs for both employers and employees who may experience any of the aforementioned characteristics. To best assess potential components of a well-being program, three leisure activities of interest (i.e., exercise, mindfulness-based practices, and vacation) were selected. These specific activities were chosen for their alignment with the recognized domains of individual health: physical, mental, and social (“Constitution of the World Health Organization, 2006), respectively. The potential relationships between these factors will be assessed through three questions. The first two questions explore the corollary relationships that may exist between workaholism, work stress, work engagement, and overall participation in leisure activities. This research posits workaholism will be positively related to work stress (Q1:H1), while work engagement will be negatively related to workaholism (Q1:H2) and work stress (Q1:H3). Considering the relationship between worker characteristics and leisure activities, it is hypothesized that participation in leisure activities will be negatively correlated with workaholism (Q2:H1) and work stress (Q2:H2), but positively correlated with work engagement (Q2:H3). The third question considers the potential moderating influence of each identified leisure activity on the relationship between workaholism and work stress. It is anticipated that participation in exercise (Q3:H1), mindfulness-based practices (Q3:H2), and vacation (Q3:H3) will have moderating influences on the relationship between workaholism and work stress, such that as participation in each of these activities increases, the relationship between workaholism and work stress will weaken. Surveys will be dispersed through Amazon’s Mechanical Turk (MTurk) platform and will include demographic questions and study measures. To assess participation in vacation activities, select questions from de Bloom et al.’s (2011) research will be used. Correlations will be obtained to test the first six hypotheses. To test the final three hypotheses regarding the potential moderating influence of leisure activities, a multiple regression analysis and Hayes’ PROCESS (2013) will be used

Effect of Organic Manures and Inorganic Fertilizers on Fruit Yield of Tomato

Treatments with organic manure, inorganic fertilizers and their combinations showed significant differences for fruit yield and yield attributing traits. Among the treatments, application of 20 t FYM/ha along with full dose of recommended NPK i.e. 150:60:60 kg NPK / ha recorded the highest fruit yield of 428.32 and 530.55 q/ha during the year 2002 and 2003, respectively with grand mean fruit yield of 479.43 q/ha. This treatment was on par with 40 tonnes FYM + 1/2 dose of recommended NPK during 2002 and 2003, which recorded mean fruit yield of 456.17 q/ ha. Both these treatments were significantly superior to recommended inorganic NPK fertilizer treatment (435.57 q/ha) as well as to application of different doses of organic manure alone such as FYM and green manure, indicating that integration of both organic manures and inorganic fertilizers are important for obtaining higher fruit yield in tomato. Addition of organic manure besides having favourable effect on crop yield was also found to be better in maintaining soil health and growth of succeeding crop

Toxic effect of naphta exposure on respiratory system among workers in the tyre industry

A cross-sectional study was carried out on workers in a tyre manufacturing industry in Malaysia to determine the effects of naphtha exposure on lung functions and respiratory symptoms. Sixty male workers exposed to naphtha and 42 unexposed workers were selected for this study. Personal air monitoring carried out using solid sorbent tubes and low flow pumps (Model: PAS-500 Personal Air Sampler). Personal air monitoring showed that the mean air naphtha concentration was 28.50 mg/m3, the median was 28.47 mg/m3 and the inter quartile range of 1.27 mg/m3. The range was from 0.19 to 200.51 mg/m3 (PEL is 400 mg/m3). The lung function tests showed in 2 groups for all the 3 parameters (FVC%, FEV1% and FEV1/FVC) were in exposed group 96.16, 85.23 and 0.791 respectively and in Unexposed group was 113.23, 116.28 and 0.903 respectively. The lung function tests showed that there were significant difference in the 2 groups for FVC% (p < 0.001), FEV1% (p < 0.001) and FEV1/FVC% (p =0.002). Multiple linear regression test showed that monthly household income significantly influence the FVC% predicted (b = 0.003, p < 0.001) and FEV1% predicted (b = 0.006, p < 0.001). In conclusion there was an inverse relationship between air naphtha concentrations and lung functions ability. Early impairment of the respiratory system is detected on the workers who are exposed to naphtha which made up of several chemicals

Lipase Production from Bacillus subtilis using various Agricultural waste

Lipases was produced by Bacillus subtilis PCSIR NL-38 strain and rape seed oil cake as substrate. Surface fermentation of minimal media in 250ml conical flask under static conditions gave 12.81 U/ml of lipases at 40°C for 48 hours. Lipase activity was monitored titrimatrically. Optimization of physicochemical parameters indicated that PCSIR NL-38 showed maximum lipase production at pH 7 with NH4NO3 as inorganic nitrogen source, glucose as carbon source, FeSO4.7H2O as salt, with 7% inoculum size and 96 hours of incubation

Phytochemical, antimicrobial and cytotoxicity screening of ethanol extract of Acacia ehrenbergiana Hayne grown in Jazan Region of Saudi Arabia

Purpose: To explore the phytoconstituents of Acacia ehrenbergiana Hayne as well as its biological effects. Methods: Determination of phytoconstituents of ethanol extract of the plant was performed by gas chromatography-mass spectrometry (GC-MS) technique. Antibacterial screening was conducted against the isolates of Gram-positive and Gram-negative microbes while the anti-carcinogenic properties of the ethanol extract on cancerous cells were investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) cytotoxicity assay against breast MCF7, ovary cancer A2780 and colon cancer HT29 cells, respectively, in addition to normal MRC5 fibroblast cells. Results: GC-MS analysis identified 15 different phytochemicals in the ethanol extract. The extract exerted significant antimicrobial activity with the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) in the range 1.56 - 6.25 and 3.12 – 12.5 mg/L, respectively, against all test bacterial strains. Cytotoxic activity, obtained by MTT assay, was 28.81 ± 0.99, 12.50 ± 2.50, 23.90 ± 0.74 and 50.58 ± 3.24 μg/mL, against the three cancer cell lines and normal fibroblast, respectively. MTT cytotoxicity results was further confirmed by clonogenic survival assay on MCF7 cells. Conclusion: This study highlights the potential interesting ethnopharmacological applications of Acacia ehrenbergiana Hayne to treat drug-resistant pathogens as standardized extract. Keywords: Acacia ehrenbergiana, Phytochemistry, Antimicrobial, Cytotoxicit

Cyclic vomiting syndrome: Pathophysiology, comorbidities, and future research directions

Cyclic vomiting syndrome (CVS) is characterized by severe episodic emesis in adults and children. Cannabinoid hyperemesis syndrome is an increasingly recognized CVS‐like illness that has been associated with chronic cannabis use. There are significant gaps in our understanding of the pathophysiology, clinical features, comorbidities, and effective management options of CVS. Recommendations for treating CVS are based on limited clinical data, as no placebo‐controlled, randomized trials have yet been conducted. Diseases associated with CVS, including migraine, mitochondrial disorders, autonomic dysfunction, and psychiatric comorbidities, provide clues about pathophysiologic mechanisms and suggest potential therapies. We review our current understanding of CVS and propose future research directions with the aim of developing effective therapy. Establishing a multicenter, standardized registry of CVS patients could drive research on multiple fronts including developing CVS‐specific outcome measures to broaden our understanding of clinical profiles, to serve as treatment end points in clinical trials, and to provide a platform for patient recruitment for randomized clinical trials. Such a robust database would also facilitate conduct of research that aims to determine the underlying pathophysiological mechanisms and genetic basis for CVS, as well as identifying potential biomarkers for the disorder. Soliciting government and industry support is crucial to establishing the necessary infrastructure and achieving these goals. Patient advocacy groups such as the Cyclic Vomiting Syndrome Association (CVSA), which partner with clinicians and researchers to disseminate new information, to promote ongoing interactions between patients, their families, clinicians, investigators, to support ongoing CVS research and education, must be an integral part of this endeavor.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149751/1/nmo13607.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/149751/2/nmo13607_am.pd

Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association

The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the development of these evidence‐based guidelines on the management of CVS in adults, which was sponsored by the American Neurogastroenterology and Motility Society (ANMS) and the Cyclic Vomiting Syndrome Association (CVSA). GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was used and a professional librarian performed the literature search. The expert committee included the President of the CVSA who brought a patient perspective into the deliberations. The committee makes recommendations for the prophylaxis of CVS, treatment of acute attacks, diagnosis, and overall management of CVS. The committee strongly  recommends that adults with moderate‐to‐severe CVS receive a tricyclic antidepressant (TCA), such as amitriptyline, as a first‐line prophylactic medication and receive topiramate or aprepitant as alternate prophylactic medications. Zonisamide or levetiracetam and mitochondrial supplements (Coenzyme Q10, L‐carnitine, and riboflavin) are conditionally recommended as alternate prophylactic medications, either alone or concurrently with other prophylactic medications. For acute attacks, the committee conditionally recommends using serotonin antagonists, such as ondansetron, and/or triptans, such as sumatriptan or aprepitant to abort symptoms. Emergency department treatment is best achieved with the use of an individualized treatment protocol and shared with the care team (example provided). The committee recommended screening and treatment for comorbid conditions such as anxiety, depression, migraine headache, autonomic dysfunction, sleep disorders, and substance use with referral to appropriate allied health services as indicated. Techniques like meditation, relaxation, and biofeedback may be offered as complementary therapy to improve overall well‐being and patient care outcomes.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149730/1/nmo13604.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/149730/2/nmo13604_am.pd

Management of cyclic vomiting syndrome in adults: Evidence review

BackgroundThis evidence review was conducted to inform the accompanying clinical practice guideline on the management of cyclic vomiting syndrome (CVS) in adults.MethodsWe followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework and focused on interventions aimed at prophylactic management and abortive treatment of adults with CVS. Specifically, this evidence review addresses the following clinical questions: (a) Should the following pharmacologic agents be used for prophylaxis of CVS: amitriptyline, topiramate, aprepitant, zonisamide/levetiracetam, or mitochondrial supplements? (b) Should the following pharmacologic agents be used for abortive treatment: triptans or aprepitant?ResultsWe found very low‐quality evidence to support the use of the following agents for prophylactic and abortive treatment of CVS: amitriptyline, topiramate, aprepitant, zonisamide/levetiracetam, and mitochondrial supplements. We have moderate certainty of evidence for the use of triptans as abortive therapy. We found limited evidence to support the use of ondansetron and the treatment of co‐morbid conditions and complementary therapies.ConclusionsThis evidence review helps inform the accompanying guideline for the management of adults with CVS which is aimed at helping clinicians, patients, and policymakers, and should improve patient outcomes.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149694/1/nmo13605.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/149694/2/nmo13605_am.pd

Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome

Cannabis is commonly used in cyclic vomiting syndrome (CVS) due to its antiemetic and anxiolytic properties. Paradoxically, chronic cannabis use in the context of cyclic vomiting has led to the recognition of a putative new disorder called cannabinoid hyperemesis syndrome (CHS). Since its first description in 2004, numerous case series and case reports have emerged describing this phenomenon. Although not pathognomonic, a patient behavior called “compulsive hot water bathing” has been associated with CHS. There is considerable controversy about how CHS is defined. Most of the data remain heterogenous with limited follow‐up, making it difficult to ascertain whether chronic cannabis use is causal, merely a clinical association with CVS, or unmasks or triggers symptoms in patients inherently predisposed to develop CVS. This article will discuss the role of cannabis in the regulation of nausea and vomiting, specifically focusing on both CVS and CHS, in order to address controversies in this context. To this objective, we have collated and analyzed published case series and case reports on CHS in order to determine the number of reported cases that meet current Rome IV criteria for CHS. We have also identified limitations in the existing diagnostic framework and propose revised criteria to diagnose CHS. Future research in this area should improve our understanding of the role of cannabis use in cyclic vomiting and help us better understand and manage this disorder.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149684/1/nmo13606_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/149684/2/nmo13606.pd